{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,10,25]],"date-time":"2023-10-25T12:52:10Z","timestamp":1698238330004},"reference-count":24,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[1985,4,1]],"date-time":"1985-04-01T00:00:00Z","timestamp":481161600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Klin Wochenschr"],"published-print":{"date-parts":[[1985,4]]},"DOI":"10.1007\/bf01731658","type":"journal-article","created":{"date-parts":[[2005,6,13]],"date-time":"2005-06-13T01:35:20Z","timestamp":1118626520000},"page":"379-384","source":"Crossref","is-referenced-by-count":12,"title":["Hormone-active intradural spinal metastasis of a prolactinoma \u2014 A case report"],"prefix":"10.1007","volume":"63","author":[{"given":"R.","family":"Landgraf","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G.","family":"Rieder","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P.","family":"Schmiedek","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D.","family":"Clados","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"K.","family":"Bise","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"K.","family":"Werder","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"BF01731658_CR1","first-page":"431","volume":"10","author":"M Azria","year":"1979","unstructured":"Azria M, Kieckel JR, Lavene D (1979) Contribution a l'\u00e9tude de l'interaction de la triacetyloleandomycine avec l'ergotamine ou la dihydroergotamine. J Pharmacol 10:431\u2013436","journal-title":"J Pharmacol"},{"key":"BF01731658_CR2","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1210\/jcem-58-2-268","volume":"58","author":"M Bassetti","year":"1984","unstructured":"Bassetti M, Spada A, Pezzo G, Giannattasio G (1984) Bromocriptine treatment reduces the cell size in human macroprolactinomas: A morphometric study. J Clin Endocrinol Metab 58:268\u2013273","journal-title":"J Clin Endocrinol Metab"},{"key":"BF01731658_CR3","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1136\/bmj.287.6390.451","volume":"287","author":"HD Breidahl","year":"1983","unstructured":"Breidahl HD, Topliss DJ, Pike JW (1983) Failure of bromocriptine to maintain reduction in size of a macroprolactinoma. Br Med J 287:451\u2013452","journal-title":"Br Med J"},{"key":"BF01731658_CR4","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1210\/jcem-53-4-737","volume":"53","author":"PG Chiodini","year":"1981","unstructured":"Chiodini PG, Liuzzi A, Cozzi R, Verde G, Oppizzi G, Dallabonanza D, Spella B, Silvestrini F, Borghi GP, Luccarelli G, Rainer E, Horowsky R (1981) Size reduction of macroprolactinomas by bromocriptine and lisuride treatment. J Clin Endocrinol Metab 53:737\u2013743","journal-title":"J Clin Endocrinol Metab"},{"key":"BF01731658_CR5","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1111\/j.1365-2265.1983.tb03210.x","volume":"18","author":"DL Cohen","year":"1983","unstructured":"Cohen DL, Diengdoh JV, Thomas DGT, Himsworth RL (1983) An intracranial metastasis from a PRL secreting pituitary tumour. Clin Endocrinol 18:259\u2013264","journal-title":"Clin Endocrinol"},{"key":"BF01731658_CR6","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1007\/BF03350560","volume":"6","author":"D Dallabonanza","year":"1983","unstructured":"Dallabonanza D, Spelta B, Oppizzi G, Tonon C, Luccarelli G, Chiodini PG, Liuzzi A (1983) Reenlargement of macroprolactinomas during bromocriptine treatment: report of two cases. J Endocrinol Invest 6:47\u201350","journal-title":"J Endocrinol Invest"},{"key":"BF01731658_CR7","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1530\/acta.0.0920413","volume":"92","author":"T Eversmann","year":"1979","unstructured":"Eversmann T, Fahlbusch R, Rjosk H, von Werder K (1979) Persisting suppression of PRL secretion after long-term treatment with bromocriptine in patients with prolactinoma. Acta Endocrinol (Kbh) 92:413\u2013427","journal-title":"Acta Endocrinol"},{"key":"BF01731658_CR8","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1097\/00005072-195307000-00001","volume":"12","author":"EH Feiring","year":"1953","unstructured":"Feiring EH, Davidoff LM, Zimmermann HM (1953) Primary carcinoma of the pituitary. J Neuropathol Exp Neurol 12:205\u2013223","journal-title":"J Neuropathol Exp Neurol"},{"key":"BF01731658_CR9","first-page":"196","volume-title":"Physiology, Pharmacology and Clinical Findings. Monographs on Endocrinology","author":"E Fl\u00fcckiger","year":"1982","unstructured":"Fl\u00fcckiger E, del Pozo E, von Werder K (1982) Physiology, Pharmacology and Clinical Findings. Monographs on Endocrinology. Springer, Berlin Heidelberg New York, p 196"},{"key":"BF01731658_CR10","volume-title":"The invasive adenomas of the anterior pituitary","author":"G Jefferson","year":"1955","unstructured":"Jefferson G (1955) The invasive adenomas of the anterior pituitary. Sherrington Lectures No 3, University Press, Liverpool"},{"key":"BF01731658_CR11","first-page":"339","volume":"89","author":"AB King","year":"1951","unstructured":"King AB (1951) The diagnosis of carcinoma of the pituitary gland. Johns Hopkins Hosp Bull 89:339\u2013353","journal-title":"Johns Hopkins Hosp Bull"},{"key":"BF01731658_CR12","first-page":"343","volume":"39","author":"JE Kraus","year":"1945","unstructured":"Kraus JE (1945) Neoplastic diseases of the human hypophysis. Arch Pathol 39:343\u2013349","journal-title":"Arch Pathol"},{"key":"BF01731658_CR13","first-page":"97","volume-title":"Central and Peripheral Regulation of Prolactin Function","author":"F Labrie","year":"1980","unstructured":"Labrie F, Ferland L, DiPaolo T, Veilleux R (1980) Modulation of prolactin secretion by sex steroids and thyroid hormones. In: MacLeod RM, Scapagnini U (eds) Central and Peripheral Regulation of Prolactin Function. Raven Press, New York, p 97\u2013113"},{"key":"BF01731658_CR14","first-page":"94","volume":"22","author":"AM Landolt","year":"1975","unstructured":"Landolt AM (1975) Ultrastructure of human sella tumors. Acta Neurochir Suppl 22:94\u2013103","journal-title":"Acta Neurochir Suppl"},{"key":"BF01731658_CR15","doi-asserted-by":"crossref","first-page":"615","DOI":"10.3171\/jns.1981.55.4.0615","volume":"55","author":"NA Martin","year":"1981","unstructured":"Martin NA, Hales M, Wilson CB (1981) Cerebellar metastasis from a prolactinoma during treatment with bromocriptine. J Neurosurg 55:615\u2013619","journal-title":"J Neurosurg"},{"key":"BF01731658_CR16","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1136\/jnnp.36.2.199","volume":"36","author":"KM Ogilvy","year":"1973","unstructured":"Ogilvy KM, Jakubowski J (1973) Intracranial dissemination of pituitary adenomas. J Neurol Neurosurg Psychiatry 36:199\u2013205","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"BF01731658_CR17","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1210\/jcem-38-4-714","volume":"38","author":"AD Rogol","year":"1974","unstructured":"Rogol AD, Rosen SW (1974) Prolactin of apparent large molecular size: The major immunoactive prolactin component in plasma of a patient with a pituitary tumor. J Clin Endocrinol Metab 38:714\u2013717","journal-title":"J Clin Endocrinol Metab"},{"key":"BF01731658_CR18","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1111\/j.1365-2362.1977.tb01580.x","volume":"7","author":"G Schwinn","year":"1977","unstructured":"Schwinn G, Dirks H, McIntosh C, K\u00f6bberling J (1977) Metabolic and clinical studies on patients with acromegaly treated with bromocriptine over 22 months. Eur J Clin Invest 7:101\u2013107","journal-title":"Eur J Clin Invest"},{"key":"BF01731658_CR19","doi-asserted-by":"crossref","first-page":"928","DOI":"10.1210\/jcem-39-5-928","volume":"39","author":"HK Suh","year":"1974","unstructured":"Suh HK, Frantz AG (1974) Size heterogeneity of human prolactin in plasma and pituitary extracts. J Clin Endocrinol Metab 39:928\u2013935","journal-title":"J Clin Endocrinol Metab"},{"key":"BF01731658_CR20","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1210\/jcem-53-3-480","volume":"53","author":"MO Thorner","year":"1981","unstructured":"Thorner MO, Perryman RL, Rogol AD, Conway BP, MacLeod RM, Login IS, Morris JL (1981) Rapid changes of prolactinoma volume after withdrawal and reinstitution of bromocriptine. J Clin Endocrinol Metab 53:480\u2013483","journal-title":"J Clin Endocrinol Metab"},{"key":"BF01731658_CR21","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1530\/acta.0.1010491","volume":"101","author":"W V\u00f6lker","year":"1982","unstructured":"V\u00f6lker W, Gehring WG, Berning R, Schmidt RC, Schneider J, von zur M\u00fchlen A (1982) Impaired pituitary response to bromocriptine suppression: reversal after bromocriptine plus tamoxifen. Acta Endocrinol (Khb) 101:491\u2013500","journal-title":"Acta Endocrinol"},{"key":"BF01731658_CR22","doi-asserted-by":"crossref","first-page":"1908","DOI":"10.1136\/bmj.284.6333.1908","volume":"284","author":"JAH Wass","year":"1982","unstructured":"Wass JAH, Williams J, Charlesworth M, Kingsley DPE, Halliday AM, Doniach I, Rees LH, McDonald WI, Besser GM (1982) Bromocriptine in management of large pituitary tumours. Br Med J 284:1908\u20131911","journal-title":"Br Med J"},{"key":"BF01731658_CR23","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/0014-5793(74)80454-0","volume":"47","author":"K Werder von","year":"1974","unstructured":"von Werder K, Clemm C (1974) Evidence for \u201cbig\u201d and \u201clittle\u201d components of circulating immunoreactive prolactin in humans. FEBS Lett 47:181\u2013184","journal-title":"FEBS Lett"},{"key":"BF01731658_CR24","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1007\/BF03346770","volume":"1","author":"K Werder von","year":"1978","unstructured":"von Werder K, Fahlbusch R, Landgraf R, Pickardt CR, Rjosk HK, Scriba PC (1978) Treatment of patients with prolactinomas. J Endocrinol Invest 1:47\u201358","journal-title":"J Endocrinol Invest"}],"container-title":["Klinische Wochenschrift"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF01731658.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/BF01731658\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF01731658","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,8]],"date-time":"2019-05-08T14:09:18Z","timestamp":1557324558000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/BF01731658"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1985,4]]},"references-count":24,"journal-issue":{"issue":"8","published-print":{"date-parts":[[1985,4]]}},"alternative-id":["BF01731658"],"URL":"https:\/\/doi.org\/10.1007\/bf01731658","relation":{},"ISSN":["0023-2173","1432-1440"],"issn-type":[{"value":"0023-2173","type":"print"},{"value":"1432-1440","type":"electronic"}],"subject":[],"published":{"date-parts":[[1985,4]]}}}